Affordable Access

Urinary neurotransmitter testing: considerations of spot baseline norepinephrine and epinephrine

Authors
Publisher
Dove Press
Publication Date
Keywords
  • Research And Reports In Urology
Disciplines
  • Medicine

Abstract

Marty Hinz1 Alvin Stein2 Thomas Uncini31Clinical Research, NeuroResearch Clinics Inc., Cape Coral, FL, USA; 2Stein Orthopedic Associates, Plantation, FL, USA; 3DBS Laboratories, Duluth, MN, USABackground: The purpose of this paper is to present the results of statistical analysis of spot baseline urinary norepinephrine and epinephrine assays in correlation with spot baseline urinary serotonin and dopamine findings previously published by the authors. Our research indicates a need for physicians and decision-makers to understand the lack of validity of this type of spot baseline monoamine testing when using it in the decision-making process for neurotransmitter deficiency disorders.Methods: Matched-pairs t-tests were performed for a group of subjects for whom spot baseline urinary norepinephrine and epinephrine assays were performed on samples collected on different days then paired by subject.Results: The reported laboratory test results for urinary serotonin, dopamine, norepinephrine, and epinephrine, obtained on different days from the same subjects, differed significantly and were not reproducible.Conclusion: Spot baseline monoamine assays, in subjects not suffering from a monoamine-secreting tumor, such as pheochromocytoma or carcinoid syndrome, are of no value in decision-making due to this day-to-day variability and lack of reproducibility. While there have been attempts to integrate spot baseline urinary monoamine assays into treatment of peripheral or central neurotransmitter-associated disease states, diagnosis of neurotransmitter imbalances, and biomarker applications, significant differences in day-to-day reproducibility make this impossible given the known science as it exists today.Keywords: neurotransmitter testing, epinephrine, norepinephrine, dopamine, serotonin

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Urinary neurotransmitter testing: considerations o...

on Open Access Journal of Urology Jan 01, 2011

Urinary neurotransmitter testing: considerations o...

on Open access journal of urology 2011

Validity of urinary monoamine assay sales under th...

on International Journal of Nephr... Jan 01, 2011

Validity of urinary monoamine assay sales under th...

on International journal of nephr... 2011
More articles like this..